samedan logo
 
 
spacer
home > pmps > summer 2019 > considering human factors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Considering Human Factors

The healthcare market is experiencing a paradigm shift as patients are being encouraged to take greater control of their own treatment therapies, primarily through self-administered injection devices. Concurrently, biologics are becoming increasingly prevalent, which, due to their large volume and high viscosity, have proved challenging for traditional self-injection systems.

Pharmaceutical and biotechnology companies have responded with an increased focus on wearable injection devices for subcutaneous drug delivery, often citing ease of use and patient centricity as the primary advantages over traditional syringes or infusion pumps. However, developing safe drug delivery systems that are user-friendly and encourage patient adherence to treatment routines entail a number of significant challenges. These challenges are further compounded when it comes to self-administration devices for situations where there is no healthcare professional present.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
Dr Andrei Yosef is CEO of Sorrel Medical, a medical device company focused on the development and manufacture of pre-filled wearable drug delivery solutions for easy and efficient self-administration. Andrei is a leading expert in drug delivery device technology and high-end development processes, having served in several executive positions at Q Core Medical, a leading developer of smart infusion systems for hospital and ambulatory care settings. He holds a PhD in Biomedical Engineering and an MA in Mechanical Engineering, both from the Technion Israel Institute of Technology.
spacer
Andrei Yosef
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cerba Research and ACT Genomics Announce Strategic Joint Venture CerbACT Asia

This expansion of the precision medicine offering includes central labs, flow cytometry, histopathology, and translational science laboratory services. Deep scientific expertise from both sides of this strategic alliance will support new growth areas for biotech and pharma clients globally and drive better patient outcomes across all phases of clinical trials.
More info >>

White Papers

ConsulTech GmbH

ConsulTech GmbH

ConsulTech is a consulting company founded in 1992. Since then, we have been supporting biotech-nology, pharmaceutical and medical technology companies as well as research institutions with the entire process of setting-up and executing proposals for R&D projects. In projects funded by the European Commission, ConsulTech supports the coordinator by resuming administrative tasks allow-ing coordinators and partners to fully concentrate on the scientific and technical success of the pro-ject. We solve financial and administrative issues, organise meetings, take care of the timely delivery of milestones and reports and much more.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement